IDEXX Laboratories, Inc. (IDXX) on Decifer

Decifer ranks IDXX number 184 of 277 tracked names on durable business quality.

Why it ranks here

• It earns strong returns on the money it puts to work, around 40% and it turns most of its profit into real cash.
• Revenue is growing about 10% a year, profits grew 22% over the past year, and growth is speeding up, not slowing down.
• It keeps a high share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power, with profitability widening as it grows.
• and has the balance sheet to fund its growth.
• It is not watering down its owners with new shares and it returns cash to shareholders.
• Returns around 40% mark a genuinely excellent business, but with no worldview role and momentum of 4 out of 35 there is no stated reason for it to grow beyond its own pace.

The current read

The evidence on IDXX lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Healthcare, Biotech & Devices: IDEXX Laboratories, Inc. operates in medical - diagnostics & research. That places it inside the Healthcare, Biotech & Devices story.

Read the full IDXX research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.